Diuretics: Again the first step in the treatment of most patients with hypertension

Current Controlled Trials in Cardiovascular Medicine

Volumn 2, Issue 5, 2001, Pages 244-248

  Fuchs, F D ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Antihypertensive treatment; Diuretics

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; NIFEDIPINE; NITRENDIPINE; PLACEBO; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANKLE EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COST; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; PATIENT CARE; SIDE EFFECT; SLOW RELEASE FORMULATION; SUDDEN DEATH;

EID: 0034752484     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-2-5-244     Document Type: Article

References (37)

1. The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-III)
2. The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-IV)
3. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI)
4. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials
5. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
6. The effect of Nisoldipine as compared with Enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
7. Clinical results of the Verapamil in Hypertension and Atherosclerosis Study
8. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives
9. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS Study (INSIGHT)
10. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study
11. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) Study
12. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg
13. The classics: A tribute to the fiftieth anniversary of the randomized clinical trial
14. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients
15. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
16. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
17. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
18. Medical Research Council trial of treatment of hypertension in older adults
19. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
20. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension
21. Diuretic therapy for hypertension and the risk of primary cardiac arrest
22. Health outcomes associated with antihypertensive therapies used as first-line agents
23. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
24. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
25. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
26. What does STOP-2 tell us about management of hypertension?
27. Cardiovascular morbidity and multifactorial primary prevention: Fifteen-year follow-up of the Helsinki Businessmen Study
28. The risk of myocardial infarction associated with antihypertensive therapies
29. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
30. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
31. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlortalidone
32. Antihypertensive drug therapies and the risk of ischemic stroke
33. Treatment of Mild Hypertension Study (TOMHS): Final results
34. Single drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo
35. Randomised, double blind, multicentre comparison of hydrochlorotiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: Results of the HANE study
36. Kidney and fluids in pressures regulation. Small volume but large pressure changes